Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Rising Pharma to Launch Avodart Generic | Contract Pharma

What are you searching for?

Sign in
Breaking News

Rising Pharma to Launch Avodart Generic

FDA-approved Dutasteride softgel capsules will be available in 0.5mg

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Rising Pharmaceuticals, the finished dosage form generics subsidiary of ACETO Corporation, is launching Dutasteride softgel capsules 0.5mg, an FDA-approved generic version of GlaxoSmithKline’s Avodart.

According to IMS Health data, U.S. market sales for Dutasteride softgel capsules, which is used for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate, were approximately $452 million for the twelve months ended September 30, 2015. This product is one of the three soft gel products acquired from Par Pharmaceuticals in September 2014.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics